RCC2 promotes breast cancer progression through regulation of Wnt signaling and inducing EMT
Zhen Chen, Wenjing Wu, Yongsheng Huang, Li‐Min Xie, Yu Li, Hengxing Chen, Wenjia Li, Dong Yin, Kaishun Hu · Journal of Cancer · 2019
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2019
Abstract
Regulator of chromosome condensation 2 (RCC2), also known as TD-60, is an RCC1 family member and plays an essential role in mitosis.However, the roles of RCC2 in breast cancer are still unclear.In this study, RCC2 was found to exert oncogenic activities in breast cancer.Samples of breast cancer tissue revealed an increased level of RCC2 and a high level of RCC2 was associated with poor overall survival rate of breast cancer patients.Overexpression of RCC2 significantly enhanced cell proliferation and migration abilities of breast cancer cells in vitro and in vivo.Mechanistically, RCC2 induced epithelial-mesenchymal transition (EMT) through the activation of Wnt signaling pathway.Collectively, our study indicates that RCC2 contributes to breast cancer progression and functions as an important regulator of EMT through the activation of Wnt signaling.
Open the resolved locator · 10.7150/jca.36430
Metadata licence: OpenAlex metadata (CC0)